SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA or vector-based vaccination in the general Dutch population show distinct kinetics

SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA or vector-based vaccination in the general Dutch population show distinct kinetics

Abstract mRNA- and vector-based vaccines are used at a large scale to prevent COVID-19. We compared Spike S1-specific (S1) IgG antibodies after vaccination with mRNA-based (Comirnaty, Spikevax) or vector-based (Janssen, Vaxzevria) vaccines, using samples from a Dutch nationwide cohort. In adults 18–...

Full description

Bibliographic Details
Main Authors: Lotus L. van den Hoogen, Marije K. Verheul, Eric R. A. Vos, Cheyenne C. E. van Hagen, Michiel van Boven, Denise Wong, Alienke J. Wijmenga-Monsuur, Gaby Smits, Marjan Kuijer, Debbie van Rooijen, Marjan Bogaard-van Maurik, Ilse Zutt, Jeffrey van Vliet, Janine Wolf, Fiona R. M. van der Klis, Hester E. de Melker, Robert S. van Binnendijk, Gerco den Hartog
Format: Article
Language:English
Published: Nature Portfolio 2022-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-10020-6

Internet

https://doi.org/10.1038/s41598-022-10020-6

Similar Items